Fentanyl vs Hydromorphone for Patients on Mechanical Ventilation
(FenHydro Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two pain relief medications, fentanyl and hydromorphone, in ICU patients requiring mechanical ventilation. The goal is to determine which medication needs less overall dosing while still providing effective pain relief. Researchers focus on patients on breathing machines who need ongoing pain control. Suitable candidates for the trial are those currently using mechanical ventilation and requiring opioid pain management. As a Phase 2 trial, this research measures the treatment's effectiveness in an initial, smaller group, offering participants the chance to contribute to important findings in pain management.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Studies have shown that both fentanyl and hydromorphone are generally safe for patients requiring mechanical ventilation. Research indicates that fentanyl is well-tolerated for calming and pain relief. It is often used with other medicines like midazolam, and this combination is considered safe and more effective for calming children on ventilators. No significant increase in serious side effects was found in adults either.
Studies comparing hydromorphone directly to fentanyl show no major differences in safety. Patients using either drug did not experience significantly different outcomes regarding the duration of mechanical ventilation. Some studies noted that starting hydromorphone in the ICU might be linked to a higher chance of long-term opioid use after hospital discharge, but this did not present a safety issue during the ICU stay itself.
Both drugs are standard choices in the ICU and have long-standing safety records. Each drug's side effects are well-known, and doctors typically choose based on the patient's specific needs and the drug's characteristics.12345Why are researchers excited about this trial's treatments?
Researchers are excited about using Fentanyl and Hydromorphone for patients on mechanical ventilation because these treatments offer potentially more effective and tailored options for managing pain and sedation in the ICU. Unlike other treatments, which might rely on a single opioid, this study explores using either Fentanyl or Hydromorphone as first-line agents. Fentanyl is known for its rapid onset and short duration, which can be beneficial for adjusting sedation levels quickly. Hydromorphone, on the other hand, may provide longer-lasting relief with potentially fewer side effects. By comparing these two, researchers aim to identify the optimal approach for analgosedation that maximizes patient comfort and safety.
What evidence suggests that this trial's treatments could be effective for patients on mechanical ventilation?
This trial will compare Fentanyl and Hydromorphone as first-line agents for analgosedation in ICU patients on mechanical ventilation. Research has shown that both Fentanyl and Hydromorphone effectively calm ICU patients on breathing machines. Studies have found that Fentanyl is often preferred over morphine for these patients because it is effective and can sometimes help them come off the ventilator sooner. Additionally, research indicates that Hydromorphone is as effective as Fentanyl for sedation, with no major differences in ventilator duration. Both drugs play a crucial role in managing pain and ensuring comfort for critically ill patients.15678
Who Is on the Research Team?
Elias N Baedorf-Kassis, MD
Principal Investigator
Beth Israel Deaconess Medical Center
Are You a Good Fit for This Trial?
This trial is for patients with respiratory failure who are on mechanical ventilation in the ICU. It's designed to see if different pain medications affect patient outcomes. To join, individuals must meet certain health conditions that aren't specified here.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Patients are randomized to receive either Fentanyl or Hydromorphone as first-line therapy for analgosedation in three-month blocks
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessment of primary and secondary outcomes
Extension
Optional long-term follow-up to assess long-term outcomes and any delayed effects
What Are the Treatments Tested in This Trial?
Interventions
- Fentanyl
- Hydromorphone
Trial Overview
The FenHydro trial is testing whether Hydromorphone or fentanyl as analgesic agents can impact the amount of morphine milligram equivalents needed during mechanical ventilation. It's a head-to-head comparison in a randomized and pragmatic setting.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Patients in an ICU on a three-month period randomized to Hydromorphone will have Hydromorphone used as suggested first-line therapy for analgosedation, when clinically warranted.
Patients in an ICU on a three-month period randomized to Fentanyl will have Fentanyl used as suggested first-line therapy for analgosedation, when clinically warranted.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Beth Israel Deaconess Medical Center
Lead Sponsor
Citations
Effects of fentanyl administration in mechanically ventilated ...
The present meta-analysis showed no significant difference in the duration of mechanical ventilation or the ICU stay between patients treated with fentanyl or ...
American Journal of Respiratory and Critical Care Medicine
The data from this trial provide a reasonable basis for using fentanyl infusions in preference to morphine in invasively mechanically ventilated adults in ICU.
Opioid administration and weaning practices in ...
Replacement of fentanyl infusion by enteral methadone decreases the weaning time from mechanical ventilation: a randomized controlled trial. Crit Care, 16 ...
4.
journals.lww.com
journals.lww.com/ccmjournal/fulltext/2020/01001/940__fentanyl_driven_analgosedation_versus.901.aspxfentanyl-driven analgosedation versus traditional sedation ...
The primary outcome was duration of mechanical ventilation. Secondary outcomes included medication exposure, adverse events and patient outcomes. Results ...
Sedation in the intensive care unit with remifentanil/propofol ...
A remifentanil-based regimen for analgesia and sedation supplemented with propofol significantly reduced the time on mechanical ventilation and allowed earlier ...
Remi-fent 1—A pragmatic randomised controlled study to ...
The ICU mortality rate in the remifentanil arm was 27.6 % versus 24.3 % in the fentanyl arm; p = 0.60. Hospital mortality rate was 30.5 % in the remifentanil ...
Efficacy and Safety of Analgosedation with Fentanyl ...
Analgosedation with fentanyl appears to be a safe and effective strategy to facilitate mechanical ventilation. This regimen does not appear to ...
Efficacy and safety of fentanyl in combination with ...
Fentanyl combined with midazolam is safe and more effective than midazolam alone for sedation therapy in mechanically ventilated children.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.